PHARMA
Quarterly rpt on consolidated results for the financial period ended 30/6/2005
| PHARMANIAGA BERHAD |
|
Quarterly report for the financial period ended | 30/06/2005 |
| Quarter | 2 |
| Financial Year End | 31/12/2005 |
| The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/06/2005 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/06/2005 | 30/06/2004 | 30/06/2005 | 30/06/2004 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 242,784 | 178,644 | 470,656 | 369,949 |
| 2 | Profit/(loss) before tax | 14,312 | 16,264 | 32,561 | 36,933 |
| 3 | Profit/(loss) after tax and minority interest | 8,711 | 10,882 | 19,410 | 23,266 |
| 4 | Net profit/(loss) for the period | 8,711 | 10,882 | 19,410 | 23,266 |
| 5 | Basic earnings/(loss) per share (sen) | 8.51 | 10.77 | 19.00 | 23.05 |
| 6 | Dividend per share (sen) | 0.00 | 4.50 | 0.00 | 4.50 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 2.5100 | 2.6000 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
| Remarks : |
| The Directors do not recommend any payment of interim dividend for the current period ended 30 June 2005 (2004:interim tax exempt dividend of 4.5 sen per share). |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 18 Aug 2005 |
| Category | Financial Results |
| Reference No | CC-050817-32070 |